Clal Biotechnology Industries Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
CBI
IL0011042806
Investment Holding Companies
Sales 2022 | 370K 100K 136K | Sales 2023 | 104K 28.17K 38.33K | Capitalization | 62.27M 16.87M 22.95M |
---|---|---|---|---|---|
Net income 2022 | -61M -16.52M -22.48M | Net income 2023 | -31M -8.4M -11.43M | EV / Sales 2022 | 331 x |
Net Debt 2022 | 23.85M 6.46M 8.79M | Net Debt 2023 | 22.4M 6.07M 8.26M | EV / Sales 2023 | 814 x |
P/E ratio 2022 |
-1.6
x | P/E ratio 2023 |
-2.01
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 34.65% |
Managers | Title | Age | Since |
---|---|---|---|
Assaf Segal
CEO | Chief Executive Officer | 51 | 15-06-30 |
Liat Nissan
DFI | Director of Finance/CFO | 46 | - |
Arnon Aharon
CTO | Chief Tech/Sci/R&D Officer | 55 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 03-05-08 | |
Yuval Yanai
BRD | Director/Board Member | 71 | 15-11-17 |
Gad Keren
BRD | Director/Board Member | 73 | 20-02-16 |
1st Jan change | Capi. | |
---|---|---|
+19.83% | 80.65B | |
+68.41% | 18.93B | |
+12.47% | 17.66B | |
+10.37% | 14.81B | |
+4.25% | 13.37B | |
+6.33% | 12.06B | |
+8.66% | 11.24B | |
+37.73% | 11.08B | |
+0.25% | 10.04B |